Rheumatology Division, Escola Paulista de Medicina/Universidade Federal de São Paulo (EPM/UNIFESP), São Paulo, Brazil.
Pulmonology Division, Escola Paulista de Medicina/Universidade Federal de São Paulo (EPM/UNIFESP), São Paulo, Brazil.
Osteoporos Int. 2018 Jun;29(6):1457-1468. doi: 10.1007/s00198-018-4483-z. Epub 2018 Mar 21.
A very high rate of osteoporosis, fractures, and low lean mass was observed in patients with chronic obstructive pulmonary disease (COPD). Disease severity was associated with bone and muscle adverse outcomes, while age ≥ 63.5 years old, low lean mass, higher iPTH, and a T-score below - 2.5 were all associated with higher risk of fracture.
Osteoporosis is frequently neglected in patients with COPD. We aimed at evaluating the rate of osteoporosis, fractures, and low lean mass in patients with COPD.
Ninety-nine patients with COPD (53 women, 64.5 ± 9.6 years old, and 46 men, 65.9 ± 8.0 years old) underwent bone densitometry (DXA) with body composition analyses. Healthy individuals (N = 57) not exposed to tobacco matched by sex, age, and body mass index (BMI) were used as controls. Spirometry, routine laboratory workout, and conventional thoracolumbar radiography surveying for vertebral deformities were performed in all patients.
Osteoporosis was found in 40.4% of the COPD patients against only 13.0% of the healthy controls (p = 0.001). Vertebral fractures were seen in 24.4% of the men and 22.0% of the women with COPD. Disease severity (GOLD 3 and 4) was significantly associated with higher risk of vitamin D deficiency (p = 0.032), lower BMD (both men and women at all sites), higher frequency of osteoporosis (in women at all sites), lower skeletal mass index, and higher rate of low lean mass (in both men and women) than healthy controls and COPD patients with milder disease (GOLD 1 and 2). Age was a main predictor of vertebral fractures (OR = 1.164 (1.078-9.297); p < 0.001), while high plasma iPTH (OR = 1.045 (1.005-1.088); p = 0.029) and low ALM (OR = 0.99965 (0.99933-0.99997); p = 0.031) were predictors of non-vertebral fractures.
Highly prevalent in COPD, osteoporosis and low lean mass were associated with FEV < 50%. Age, low lean mass, high iPTH, and low bone mass were all significantly associated with fractures in COPD patients.
评估慢性阻塞性肺疾病(COPD)患者的骨质疏松症、骨折和低瘦体重发生率。
对 99 例 COPD 患者(53 名女性,64.5±9.6 岁;46 名男性,65.9±8.0 岁)进行骨密度(DXA)和身体成分分析。选择性别、年龄和体重指数(BMI)匹配的无吸烟史的健康个体(N=57)作为对照组。所有患者均行肺功能检查、常规实验室检查和常规胸腰椎 X 线检查以评估椎体畸形。
COPD 患者骨质疏松发生率为 40.4%,而健康对照组仅为 13.0%(p=0.001)。COPD 患者中,男性和女性的椎体骨折发生率分别为 24.4%和 22.0%。疾病严重程度(GOLD 3 和 4 级)与维生素 D 缺乏(p=0.032)、骨密度降低(所有部位的男性和女性)、骨质疏松发生率升高(所有部位的女性)、骨骼质量指数降低以及低瘦体重发生率升高(男性和女性)显著相关,而与疾病较轻的患者(GOLD 1 和 2 级)相比,差异有统计学意义。年龄是椎体骨折的主要预测因素(OR=1.164(1.078-9.297);p<0.001),而高血浆甲状旁腺激素(OR=1.045(1.005-1.088);p=0.029)和低瘦体重(OR=0.99965(0.99933-0.99997);p=0.031)是预测非椎体骨折的因素。
COPD 患者骨质疏松症和低瘦体重发生率较高,与 FEV<50%相关。年龄、低瘦体重、高甲状旁腺激素和低骨密度与 COPD 患者骨折显著相关。